Library / Laws / 117th Congress / Senate Bills / S. 3449
S. 3449
To require foreign establishments engaged in the manufacture, preparation, propagation, compounding, or processing of a drug or device to register with the Food and Drug Administration regardless of whether the drug or device undergoes further manufacture, preparation, propagation, compounding, or processing at a separate establishment outside the United States prior to being imported into the United States.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2022-01-10 | 1.5K | ⠃⠗⠋ |